Pfizer and Canadian REITs Lead New Dividend Stock Recommendations

Investment analysts highlighted two major dividend opportunities for investors. Pfizer (PFE) is noted for its 7.1% forward dividend yield and a price‑earnings multiple of 8.2× forward earnings, while Bristol Myers Squibb (BMY) is praised for its pipeline growth and a 2.23% price increase. Both companies are positioned as "dirt‑cheap" dividend stocks that could be bought with a $1,000 allocation.

A separate recommendation targeted Canadian investors looking to maximise tax‑free income within a TFSA. The advice suggests splitting a $14,000 portfolio among three monthly‑paying dividend stocks: SmartCentres REIT (SRU), Vital Infrastructure Property Trust (VITL) and Peyto Exploration (PEY). The REITs collectively generate about $72 in monthly income, with SmartCentres yielding 6.1% annually and Vital Infrastructure delivering a 6.4% forward yield.